IMCAS

SYMATESE - It's science of tissue regeneration

SCIENTIS - Isobionic - Amide as a new depigmenting and anti-inflammatory molecule and its combination with other depigmenting agents

RENAISSANCE - Novel exopeptide mesococktail for skin regeneration

PHARMARESEARCH - Anatomical Consideration of DOT-PN: How Should We Use It?

MARTIDERM - The synergy of pure ingredients applied on dermatological practice

LABORATOIRES URGO - Retix.C - Antioxidant and anti-inflammatory therapy for skin DNA cell protection and repair. Clinical case study

LABORATOIRES FIJIE - Intracellular targets for a new generation of injectable products - Matrix Biomodulators Novacutan BioPro

ALGENESS - The potential of Algeness filler (purified agarose gel): stable facial reshaping without oedema

Objectives: The characteristics and main clinical indications of Algeness (agarose) polysaccharide filler for deep and subcutaneous injection are outlined.

Introduction: Agarose is a completely natural polysaccharide, purified from red algae. It is not modified by a chemical cross-linking procedure. The G’ and G” measurements are two log orders higher than current hyaluronic acid gels. After subcutaneous or deep injection, it is quickly surrounded by histiocytes and macrophages and metabolised in situ over the course of months up to more than a year. Agarose has been in use for decades as a carrier for slow-release medication. It has been used as a filler for over a decade.

Materials / method: The main product characteristics are described. The main clinical, aesthetic indications are presented with clinical photography. Film fragments were selected to demonstrate the advocated injection techniques, which are similar to the techniques used with other fillers. Cadaver dissections after the injection of dyed agarose were performed to study the distribution of filler deposits.

Results: Pleasing results can be achieved by injecting agarose 2.5% or 3.5% close to bone in the temples, the lateral aspect of the eyebrows, the midface, the chin and the jawline. With agarose 1.5%, subcutaneous reshaping can be performed. Mid or long term water oedema has not been observed. The infiltrate around the filler stabilises the reshaping. Used at the initiative of the author, the absence of reactive oedema has been an advantage in delicate areas such as after submuscular injection in the forehead and the orbital margin. The stability of the result is very useful for nasal reshaping.

Conclusion: The stability of shape and volume of the deposits, enhanced by the histiocytary infiltrate surrounding them, and the absence of mid or long term oedema, makes Algeness a very useful asset for facial reshaping. In patients who need a lot of volume compensation, the filler is bridging the gap between reshaping with hyaluronic acid fillers, limited to small quantities, and surgical corrections.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作的完成感谢以下机构的支持： Algeness

ALMA LASERS - 3-Year Journey of TITANIUM Lifting in Korea: Innovative transformation from Hair Removal to Skin Lifting and Tightening Procedure

ALMA LASERS - Combining EBDs with injectables for neck and hand rejuvenation

BLUECORE - Effect of 8:2 dual-optical pulses (PTP) with a Q switched Nd:YAG

FAGRON GENOMICS - Genomic insights into Androgenetic Alopecia: SNP genotyping unveils disease pathogenesis and drug mechanism of action for personalized hair loss treatment

HIRONIC - Gentlo - Acne scar treatments

HIRONIC - RF Microneedling and Plasma combination treatment for enhanced drug delivery and skin rejuvenation

APYX MEDICAL - The future of combo procedures: Leveraging Renuvion and Liposuction in aesthetics

ISKRA MEDICAL - Interest of Tesla former in a plastic surgery practice

KORU PHARMA - Experience the luxury of healthy hair with H Bloom Booster®

KORU PHARMA - Welcome age with grace and beauty with Elitox®

VYDENCE MEDICAL - Case report on treatments with intense, micropulsed q-switched picosecond laser handpiece and fractional laser for comprehensive skin rejuvenation approach

DELEO - CELLUTION®: the ultimate technology for Cellulite treatment

ACCLARO MEDICAL - Learn about UltraClear's Versatility from a Lunchtime Treatment to our Latest Modality: Laser-Coring

VENOME - Sisthaema Hevo T - Tissue biostimulation as a safe and effective method in skin rejuvenation

Objectives: innovative biostimulation, fragmented hyaluronic acid, innovative therapy, PET treatment safety, effects at the cellular level

Introduction: Tissue stimulation is a rapidly growing field of aesthetic medicine from which we demand safe and lasting treatment results. The most controversial element of the therapy is the aspect of safe tissue stimulation that produces effects at the cellular level. As demonstrated in the scientific literature, fragmented hyaluronic acid with trehalose meets the requirements for stimulation with a high safety profile and greater durability compared to alternative ingredients.

Materials / method: To validate the efficacy and safety of SISTHAEMA HEVO T (batch 004806), a study was conducted using in vitro skin models. This research focused on the product's impact on artificially damaged skin cells, comparing it with an existing market competitor. Key areas of investigation included the promotion of recovery at various concentrations (0.5%, 0.25%, 0.125%) and the recovery rate at different time intervals (T0h, T2h, T8h, T24h). Additionally, the product's metabolism was analyzed using PET imaging.

Results: The results were statistically significant (p<0.05). The in vitro study results show that products containing non-cross-linked hyaluronic acid effectively regulate the regeneration and healing processes of damaged human skin.
In addition, the PET study showed a clear lack of inflammatory activity after implantation.

Conclusion: Biostimulation using the innovative SISTHAEMA HEVO T product formulation has a high efficacy and treatment safety profile.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

SKIN TECH PHARMA GROUP - Efficacy study of novel monophasic dermal implant containing cross-linked hyaluronic acid associated with amino acids for treatment of face & hands photoaging

小时	讲者	演讲标题	讲稿摘要	数字
10:30	Sebastien GUYON	SYMATESE - It's science of tissue regeneration		131211
10:45	Behrooz KASRAEE 医师	SCIENTIS - Isobionic - Amide as a new depigmenting and anti-inflammatory molecule and its combination with other depigmenting agents		131212
11:00	Foteini BAGEORGOU 医师	RENAISSANCE - Novel exopeptide mesococktail for skin regeneration		131213
11:15	Kyuho YI 医师	PHARMARESEARCH - Anatomical Consideration of DOT-PN: How Should We Use It?		131214
11:30	Tamara MARTINEZ VALVERDE 医师	MARTIDERM - The synergy of pure ingredients applied on dermatological practice		131215
11:45	Aleksandra LESIAK Prof	LABORATOIRES URGO - Retix.C - Antioxidant and anti-inflammatory therapy for skin DNA cell protection and repair. Clinical case study		131216
12:00	Zarema GAZITAEVA 医师	LABORATOIRES FIJIE - Intracellular targets for a new generation of injectable products - Matrix Biomodulators Novacutan BioPro		131217
12:15	Joan VANDEPUTTE 医师	ALGENESS - The potential of Algeness filler (purified agarose gel): stable facial reshaping without oedema	查看	131218
12:30	Do Young LEE 医师	ALMA LASERS - 3-Year Journey of TITANIUM Lifting in Korea: Innovative transformation from Hair Removal to Skin Lifting and Tightening Procedure		134958
12:45	Dean BERMAN 医师	ALMA LASERS - Combining EBDs with injectables for neck and hand rejuvenation		131892
13:00	Yogesh BHINGRADIA 医师	BLUECORE - Effect of 8:2 dual-optical pulses (PTP) with a Q switched Nd:YAG		134959
13:15	Gustavo TORRES DE SOUZA 医师	FAGRON GENOMICS - Genomic insights into Androgenetic Alopecia: SNP genotyping unveils disease pathogenesis and drug mechanism of action for personalized hair loss treatment		131220
13:30	Zahide ERIS ZORLU 医师	HIRONIC - Gentlo - Acne scar treatments		131221
13:45	Christian FAYARD 医师	HIRONIC - RF Microneedling and Plasma combination treatment for enhanced drug delivery and skin rejuvenation		131222
14:00	Jordi MIR BATLLE 医师	APYX MEDICAL - The future of combo procedures: Leveraging Renuvion and Liposuction in aesthetics		131223
14:15	Juan Antonio BAUTISTA	ISKRA MEDICAL - The present and the future of magnetic stimulation in aesthetics		131224
14:30	Matthieu BEUSTES STEFANELLI 医师	ISKRA MEDICAL - Interest of Tesla former in a plastic surgery practice		131225
14:45	Joao BATISTA CUNHA DE ARAUJO 医师	KORU PHARMA - Experience the luxury of healthy hair with H Bloom Booster®		131226
15:00	Joao BATISTA CUNHA DE ARAUJO 医师	KORU PHARMA - Welcome age with grace and beauty with Elitox®		131893
15:15	Valeria CAMPOS 医师	VYDENCE MEDICAL - Case report on treatments with intense, micropulsed q-switched picosecond laser handpiece and fractional laser for comprehensive skin rejuvenation approach		134960
15:30	Marc BENATAR	DELEO - CELLUTION®: the ultimate technology for Cellulite treatment		131227
15:45	David J GOLDBERG Prof	ACCLARO MEDICAL - Learn about UltraClear's Versatility from a Lunchtime Treatment to our Latest Modality: Laser-Coring		131228
16:00	Izabela ZALESKA 医师	VENOME - Sisthaema Hevo T - Tissue biostimulation as a safe and effective method in skin rejuvenation	查看	131229
16:15	Javed HUSSAIN 医师	SKIN TECH PHARMA GROUP - Efficacy study of novel monophasic dermal implant containing cross-linked hyaluronic acid associated with amino acids for treatment of face & hands photoaging		131559
16:30	Sabika KARIM 医师	ERCHONIA LASERS - Fat Loss without the side effects		131560
16:45	Bernard SILLAM	SINGCLEAN - Singderm®, perfect monophasic HA filler for full face rejuvenation		131561
17:00	Monika HEILIGMANN	MONIKA HEILIGMANN PARIS - Non-invasive and lip perfecting innovative solutions		131562

IMCAS World Congress 2024
大会日程

OS 001 TO 006

Open Stage - Industry sponsored lectures

本场演讲内容

推荐会议

IMCAS World Congress 2024 大会日程

OS 001 TO 006

Open Stage - Industry sponsored lectures

本场演讲内容

推荐会议

IMCAS World Congress 2024
大会日程

本场演讲内容